Posted by Marilyn McGoldrick on Apr 11, 2014 10:49:00 AM NOTE: The trial judge on this case later reduced the award to $36.8 million, by lowering the plaintiffs’ $6 billion award for punitive damages against Takeda to roughly $27.7 million and the $3 billion dollar...
Over the course of the last year, there have been a number of class action lawsuits filed against major retailers. These class actions allege that the retailers violated their duty to their customers by collecting personally identifiable information (also known as Personal Identifying Information, abbreviated PII) as they accepted credit card payment. Many, but not all, of these cases have been filed in Massachusetts, because Massachusetts has case law specifically forbidding this practice by retailers.
On Tuesday, the Food and Drug Administration (FDA) announced it is investigating a possible increased risk for heart failure associated with the diabetes drug Saxagliptin, manufactured by Bristol-Myers Squibb and AstraZeneca and marketed as Onglyza and Kombiglyze XR. The FDA has requested full data from the results of a recent clinical trial assessing the cardiovascular safety and efficacy of many current medications used to treat type 2 diabetes, including Saxagliptin (SAVOR trial). The FDA intends to further investigate the 27% increased risk of hospitalization for heart failure among patients taking the Saxagliptin reported in the study. The findings were first reported in August of 2013 at the European Society of Cardiology meeting and subsequently published in the New England Journal of Medicine.
Biomet, Inc. and counsel for Plaintiffs reached an agreement to settle all cases currently pending in the Biomet MDL (In Re Biomet M2A Magnum Hip Implant Products Liability Litigation, MDL 2391) and any future cases filed on or before April 15, 2014. To be eligible for compensation a plaintiff must have been implanted with a Biomet M2a 38 or M2A Magnum hip replacement system and underwent surgery to revise the device more than 180 days after it was implanted.
Posted by Marilyn McGoldrick on Feb 3, 2014 3:32:00 PM On Friday, the federal judge overseeing the Ethicon transvaginal mesh (TVM) litigation ruled that Johnson & Johnson (J&J) and its subsidiary, Ethicon, will not be allowed to introduce evidence that...
The first federal MDL Bellwether trial in the Actos litigation (MDL 2299) began yesterday in Lafayette, Louisiana before the Honorable Rebecca Doherty. The plaintiff is Terrance Allen, a New York man who was prescribed the diabetes drug Actos from 2004 until 2011 when he was diagnosed with bladder cancer. Allen’s opening statement asserts that the evidence will show that Takeda had information about Actos causing bladder cancer for over 10 years and withheld this information from doctors and patients. Actos also raises the risk of heart disease, although that is not at issue in this trial.
A new study of children born near fracking operations in populated areas of Colorado has found that natural gas development within a 10-mile radius of the residences of pregnant women is positively associated with having a child with a congenital heart defect, and possibly associated with having a child born with a neural tube birth defect.
By: Patricia M. Flannery, Esq. on Jan 6, 2014 2:01:00 PM Thornton Law Firm, LLP are pleased to announce that associate Christian Uehlein has been named a partner in the firm. Christian focuses his work at Thornton Law Firm on representing clients in two different...
Do you know the average age of a homeless person in Massachusetts? It’s …. 8. Eight years old is the average age of a homeless person in our state. Families are now the homeless population’s fastest growing segment, comprising more than one-third of the homeless population. According to the Massachusetts’ Coalition for the Homeless, as of October 29, 2013, there were approximately 4,100 families with children and pregnant women in Massachusetts’ Emergency Assistance (EA) shelter program. On any given night in Greater Boston, more than 7,000 people are homeless, including 3,000 children.
By: Patricia M. Flannery, Esq. on Nov 22, 2013 10:51:00 AM Thornton Law Firm is proud to support its two “Movember” participants, Dan Lustick and Charles Moore. Dan and Charles are both valuable members of our birth defect practice area. Dan, who holds a...
Andrea Marino Landry, a Thornton Law Firm partner and associated with the firm since 2005, was recently appointed an associate adjunct professor at New England Law | Boston, teaching public health law. Andrea has worked in the firm’s asbestos, tobacco, and birth defect practice areas during her time at the firm.
Depuy Orthopaedics, Inc., announced that it will pay approximately 2.5 billion dollars to settle claims for individuals who were implanted with the recalled Depuy ASR™ XL Acetabular Hip System or the ASR™ Hip Resurfacing System and who had revision surgery to replace their ASR hip by August 31, 2013.
